IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

May 2005 (Vol: 2005, Issue: 59)

Next Issue >>

Section: Business Commentaries
The Maturing of Biotech Published: 1 May-2005
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
ALTANA Pharma AG Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Alvesco (ciclesonide) Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Competition Forces Organon and J&J to Terminate Co-Promotion of Risperdal® Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Pfizer Validates Coley Pharmaceutical's ProMune#8482; with Deal Worth US$515 M Plus Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Abbott Takes First Pick at BioCurex Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Deal Making Trends of Top Pharma Companies Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Erectile Dysfunction Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Gilead Begins to Fill the Hole in its Pipeline Published: 5 May-2005
By: Business Review Editor
Abstract
Section: Licensing
Arakis and Vectura in COPD Alliance with Novartis Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Tanox to Buy Sunol Tissue Factor Assets Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Solvay Looks to Fournier to Expand Drugs Business Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
IDM’s and Epimmune’s Merger Highlights Biotech Funding Difficulties Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Curis and Genentech Join Forces Again Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in